FDA Extends Comment Period for First Amendment Issues

FDA Extends Comment Period for First Amendment Issues

ROCKVILLE, Md.--The Food and Drug Administration(FDA) extended the comment period for public opinion on FDA's First Amendmentissues (May 16 Federal Register) until Sept. 13. The comment period forresponses to those comments has been extended to Oct. 28, 2002. Electroniccomments can be submitted at http://frwebgate.access.gpo.gov